SCHEMBL752667

SCHEMBL752667

c1ccc2cc3c(cc2c1)sc1cc2c(cc13)sc1cc3ccccc3cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.43
ALDH1A1 P00352 5/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HIF1A Q16665 1/20 0.40
CYP1B1 Q16678 1/20 0.40
CA12 O43570 2/20 0.39
CA9 Q16790 2/20 0.39
NQO1 P15559 1/20 0.39
CYP2A6 P11509 5/20 0.35
ASIC3 Q9UHC3 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.35
MGLL Q99685 1/20 0.35
ALOX12 P18054 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
TSHR P16473 1/20 0.35
NQO2 P16083 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11990859 0.97 GPR3 (0.46) GPR3ALDH1A1HSD17B10MAPTHPGD
SCHEMBL30888167 0.97 GPR3 (0.46) GPR3ALDH1A1HSD17B10MAPTHPGD
SCHEMBL754840 0.95 GPR3 (0.40) GPR3ALDH1A1HSD17B10MAPTHPGD
SCHEMBL16024612 0.95 GPR3 (0.43) GPR3ALDH1A1HSD17B10MAPTHPGD
SCHEMBL13250620 0.92 GPR3 (0.42) GPR3ALDH1A1HSD17B10MAPTHPGD
SCHEMBL23916959 0.91 GPR3 (0.61) GPR3ALDH1A1HSD17B10MAPTHPGD
SCHEMBL17228832 0.91 GPR3 (0.61) GPR3ALDH1A1HSD17B10MAPTHPGD
SCHEMBL2742087 0.88 GPR3 (0.64) GPR3ALDH1A1HSD17B10MAPTHPGD
SCHEMBL29450187 0.88 GPR3 (0.64) GPR3ALDH1A1HSD17B10MAPTHPGD
SCHEMBL754864 0.87 CYP2A6 (0.36) GPR3ALDH1A1HSD17B10MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2966077-B1 CHALCOGEN-CONTAINING ORGANIC COMPOUND AND USE THEREFOR JNC CORP (JP) 2020-04-01 EP disclosed
EP-2966077-B1 CHALCOGEN-CONTAINING ORGANIC COMPOUND AND USE THEREFOR JNC CORP (JP) 2020-04-01 EP disclosed
US-20190006603-A1 COMPOSITION FOR MANUFACTURING ORGANIC SEMICONDUCTOR DEVICE DAICEL CORPORATION (JP) 2019-01-03 US disclosed
US-10074818-B2 Transistor TOPPAN FORMS CO., LTD. (JP) 2018-09-11 US disclosed
US-9853225-B2 Chalcogen-containing organic compound and a use thereof JNC CORPORATION (JP) 2017-12-26 US disclosed
US-9853225-B2 Chalcogen-containing organic compound and a use thereof JNC CORPORATION (JP) 2017-12-26 US disclosed
US-9853225-B2 Chalcogen-containing organic compound and a use thereof JNC CORPORATION (JP) 2017-12-26 US disclosed
US-20170288152-A1 COMPOSITION FOR FORMING ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR FILM, MANUFACTURING METHOD THEREOF, ORGANIC SEMICONDUCTOR ELEMENT, AND MANUFACTURING METHOD THEREOF FUJIFILM CORPORATION (JP) 2017-10-05 US disclosed
US-20170288151-A1 COMPOSITION FOR FORMING ORGANIC SEMICONDUCTOR FILM AND ORGANIC SEMICONDUCTOR ELEMENT FUJIFILM CORPORATION (JP) 2017-10-05 US disclosed
US-20170288151-A1 COMPOSITION FOR FORMING ORGANIC SEMICONDUCTOR FILM AND ORGANIC SEMICONDUCTOR ELEMENT FUJIFILM CORPORATION (JP) 2017-10-05 US disclosed
EP-2966077-A1 CHALCOGEN-CONTAINING ORGANIC COMPOUND AND USE THEREFOR JNC Corporation (JP) 2016-01-13 EP disclosed
US-20150166560-A1 ORGANIC THIN FILM TRANSISTOR, ORGANIC SEMICONDUCTOR THIN FILM, AND ORGANIC SEMICONDUCTOR MATERIAL FUJIFILM CORPORATION (JP) 2015-06-18 US disclosed
US-20150166560-A1 ORGANIC THIN FILM TRANSISTOR, ORGANIC SEMICONDUCTOR THIN FILM, AND ORGANIC SEMICONDUCTOR MATERIAL FUJIFILM CORPORATION (JP) 2015-06-18 US disclosed
WO-2014136827-A1 CHALCOGEN-CONTAINING ORGANIC COMPOUND AND USE THEREFOR JNC株式会社 (JP) 2014-09-12 WO disclosed
EP-2067782-B1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND THEIR PRODUCTION METHODS TOSOH CORP (JP) 2014-08-13 EP disclosed
US-8138355-B2 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same TOSOH CORPORATION (JP) 2012-03-20 US disclosed
US-8138355-B2 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same TOSOH CORPORATION (JP) 2012-03-20 US disclosed
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME TOSOH CORPORATION (JP) 2009-10-22 US disclosed
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME TOSOH CORPORATION (JP) 2009-10-22 US disclosed
EP-2067782-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND THEIR PRODUCTION METHODS Tosoh Corporation (JP) 2009-06-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME AS3MT, TERT, TEAD1 GPR3 3625/4885ALDH1A1 2196/4885HSD17B10 3443/4885
US-20150166560-A1 ORGANIC THIN FILM TRANSISTOR, ORGANIC SEMICONDUCTOR THIN FILM, AND ORGANIC SEMICONDUCTOR MATERIAL OR10J3, SLC19A1, SLCO2A1 GPR3 3888/4885ALDH1A1 1934/4885HSD17B10 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.